Expertise in
8
conditions

Christelle Ferra

Barcelona, CT, ES 
Expertise in
8
conditions
Barcelona, CT, ES 

Overview

Christelle Ferra practices practicing medicine in Barcelona, Spain.

Ms. Ferra is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Graft Versus Host Disease (GvHD), Chronic Lymphocytic Leukemia (CLL), Leukemia, Bone Marrow Transplant, and Bone Graft.

She is actively involved in clinical research, co-authoring 75 peer reviewed articles and participating in 4 clinical trials.

Gender

Female

Locations

Barcelona, CT, Spain
Other Locations
Vic, CT, Spain
Badalona, CT, Spain
Girona, CT 17007, Spain
Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Prospective Multicenter Open-label, Not Controlled Phase Ib-II Clinical Trial to Assess the Safety and Immunologic Efficacy of Virus-specific T Lymphocytes From the Best Donor in Receptors of Hematopoietic Progenitor Allogeneic Transplant
A Prospective Multicenter Open-label, Not Controlled Phase Ib-II Clinical Trial to Assess the Safety and Immunologic Efficacy of Virus-specific T Lymphocytes From the Best Donor in Receptors of Hematopoietic Progenitor Allogeneic Transplant
Enrollment Status: Completed
Publish Date: January 24, 2024
Intervention Type: Drug
Study Drug: Activated T-lymphocytes
Study Phase: Phase 1/Phase 2
A Multicenter, Non-randomized, Open Label Study to Evaluate the Efficacy and Security of Ibrutinib Followed by Ibrutinib Consolidation in Combination With Ofatumumab in Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
A Multicenter, Non-randomized, Open Label Study to Evaluate the Efficacy and Security of Ibrutinib Followed by Ibrutinib Consolidation in Combination With Ofatumumab in Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
Enrollment Status: Unknown
Publish Date: September 16, 2022
Intervention Type: Drug
Study Drug: Ibrutinib
Study Phase: Phase 2
Ofatumumab as Part of the Reduced Intensity Conditioning Regimen for Patients With High Risk Chronic Lymphocytic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation: a Pilot Study by GETH and GELLC
Ofatumumab as Part of the Reduced Intensity Conditioning Regimen for Patients With High Risk Chronic Lymphocytic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation: a Pilot Study by GETH and GELLC
Enrollment Status: Completed
Publish Date: May 06, 2022
Intervention Type: Drug
Study Drug: Ofatumumab
Study Phase: Phase 2
Prophylactic Infusion of Donor Lymphocytes in Cord Blood Transplantation
Prophylactic Infusion of Donor Lymphocytes in Cord Blood Transplantation
Enrollment Status: Completed
Publish Date: December 08, 2021
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 3 Less Clinical Trials

75 Total Publications

Adverse Social Determinants Independently Predict Outcomes After Allogeneic HSCT.
Adverse Social Determinants Independently Predict Outcomes After Allogeneic HSCT.
Journal: Transplantation and cellular therapy
Published: January 08, 2026

Frequently Asked Questions about Christelle Ferra

Is Christelle Ferra a top-rated expert for Bone Marrow Transplant?

MediFind is an objective health platform that identifies experts based on real-world data. Christelle Ferra is classified as an Distinguished expert for Bone Marrow Transplant, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Christelle Ferra participate in research or clinical trials?

Yes. Christelle Ferra has published 75 articles and abstracts on conditions like Bone Marrow Transplant. You can view a list of Christelle Ferra's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Ferra's expertise for a condition
ConditionClose
    View All 15 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile